N-substituted 4-aminoquinazoline derivatives and methods of use
US10273229B2 · kind B2 · utility
0Cited by
6References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2015 |
| Grant date | Apr 30, 2019 |
| Priority date | — |
| Expiry date | Sep 18, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides kinase inhibitor analogs with improved properties, such as improved efficacy, pharmacokinetics, safety, and specificity. In some embodiments, the present invention provides lapatinib analogs that provide therapeutic benefits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.